These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16120159)

  • 1. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin.
    Shergill B; Orteu CH; McBride SR; Rustin MH
    Br J Dermatol; 2005 Sep; 153(3):650-2. PubMed ID: 16120159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma.
    Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K
    Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
    Karim A; Lawlor F; Black MM
    Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin.
    Kulczycki A; Nelson M; Eisen A; Heffernan M
    Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins control scleromyxoedema.
    Righi A; Schiavon F; Jablonska S; Doria A; Blasczyk M; Rondinone R; Todesco S; Matucci Cerinic M
    Ann Rheum Dis; 2002 Jan; 61(1):59-61. PubMed ID: 11779761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
    Relkin NR; Szabo P; Adamiak B; Burgut T; Monthe C; Lent RW; Younkin S; Younkin L; Schiff R; Weksler ME
    Neurobiol Aging; 2009 Nov; 30(11):1728-36. PubMed ID: 18294736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothyroidism: does treatment cure dementia?
    Clarnette RM; Patterson CJ
    J Geriatr Psychiatry Neurol; 1994; 7(1):23-7. PubMed ID: 8192826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of scleromyxoedema with hydroxychloroquine.
    Terheyden P; Becker JC; Lurz C; Kahaly GJ; Bröcker EB
    J Dtsch Dermatol Ges; 2003 Jan; 1(1):30-5. PubMed ID: 16285290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open-label clinical trial using an objective score of clinical evaluation system.
    Guarneri A; Cioni M; Rongioletti F
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1157-1160. PubMed ID: 28370513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.
    Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B
    Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hashimoto encephalopathy--a difficult differential diagnosis. A case report of reversible dementia and psychosis].
    Nunnemann C; Kratz T
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):610-5. PubMed ID: 18833507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.
    Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K
    Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose dexamethasone in scleromyxedema: report of 2 additional cases.
    Kreuter A; Altmeyer P
    J Am Acad Dermatol; 2005 Oct; 53(4):739-40. PubMed ID: 16198811
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute cerebral symptomatology, a rare presentation of scleromyxedema.
    Ochitill HN; Amberson J
    J Clin Psychiatry; 1978 May; 39(5):471-5. PubMed ID: 417072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.